QTc prolongation after regadenoson administration

被引：1
作者：
Gupta, Ankur [1 ]
Borer, Steven [1 ]
Heller, Gary V. [1 ]
机构：
[1] Hartford Hosp, Div Nucl Cardiol, Hartford, CT 06102 USA
来源：
JOURNAL OF NUCLEAR CARDIOLOGY | 2012年 / 19卷 / 05期
关键词：
SELECTIVE A(2A) AGONIST; INTERVAL;
D O I：
10.1007/s12350-012-9589-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1080 / 1082
页数：3
相关论文
共 5 条
  • [1] Effects of Age, Gender, Obesity, and Diabetes on the Efficacy and Safety of the Selective A2A Agonist Regadenoson Versus Adenosine in Myocardial Perfusion Imaging Integrated ADVANCE-MPI Trial Results
    Cerqueira, Manuel D.
    Nguyen, Patricia
    Staehr, Peter
    Underwood, S. Richard
    Iskandrian, Ami E.
    [J]. JACC-CARDIOVASCULAR IMAGING, 2008, 1 (03) : 307 - 316
  • [2] Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging
    Hendel, RC
    Bateman, TM
    Cerqueira, MD
    Iskandrian, AE
    Leppo, JA
    Blackburn, B
    Mahmarian, JJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (11) : 2069 - 2075
  • [3] TALBOT S, 1973, BRIT HEART J, V35, P288
  • [4] TALBOT S, 1973, BRIT HEART J, V35, P684
  • [5] Regadenoson, a Novel Pharmacologic Stress Agent for Use in Myocardial Perfusion Imaging, Does Not Have a Direct Effect on the QT Interval in Conscious Dogs
    Zhao, Gong
    Serpllion, Sabrina
    Shryock, John
    Messina, Eric
    Xu, Xiaobin
    Ochoa, Manuel
    Belardinelli, Luiz
    Hintze, Thomas H.
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2008, 52 (05) : 467 - 473
1